Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1651 to 1665 of 7691 results

  1. Danis stent for acute oesophageal variceal bleeding (MTG57)

    Evidence-based recommendations on Danis stent for acute oesophageal variceal bleeding.

    Medical technologies guidance
    Published
    31 March 2021
    View recommendations

    Sections for MTG57

  2. Plus Sutures for preventing surgical site infection (MTG59)

    Evidence-based recommendations on Plus Sutures for preventing surgical site infection.

    Medical technologies guidance
    Published
    28 June 2021
    View recommendations

    Sections for MTG59

  3. Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 TS ID 11827

    Awaiting development [GID-TA11313] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. ABP 959 (eculizumab biosimilar) for treating paroxysmal nocturnal haemoglobinuria TS ID 10250

      Status ...

    Technology appraisal guidance
    Topic selection

  5. STS101 for treating acute migraine TS ID 11782

    Awaiting development [GID-TA11147] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  6. Paclitaxel + XR17 (Paclical) with carboplatin for ovarian cancer TS ID 5462

      Status ...

    Technology appraisal guidance
    Topic selection

  7. Riluzole oral film for treating amyotrophic lateral sclerosis TS ID 11779

      Status ...

    Technology appraisal guidance
    Topic selection

  8. Gantenerumab for treating early Alzheimer's disease TS ID 10668

    Awaiting development [GID-TA11072] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Dersimelagon for treating erythropoietic protoporphyria and X-linked protoporphyria in people 12 years and over TS ID 10392

    Awaiting development [GID-TA11085] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Crizanlizumab for preventing recurrent vaso-occlusive crises in sickle cell disease in young people aged 12 to 17 TS ID 10766

      Status ...

    Technology appraisal guidance
    Topic selection

  11. Teduglutide for treating short bowel syndrome in babies 4 to 12 months [TS ID 10755]

      Status ...

    Technology appraisal guidance
    Topic selection

  12. Venetoclax with ibrutinib for treating relapsed mantle cell lymphoma [ID3879]

    Awaiting development [GID-TA10774] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Rezafungin for untreated invasive candidiasis TS ID 10768

      Status ...

    Technology appraisal guidance
    Topic selection

  14. Afamitresgene autoleucel for previously treated MAGE-A4 positive advanced synovial sarcoma or myxoid round cell liposarcoma [ID4064]

    Awaiting development [GID-TA11040] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cholangiocarcinoma or pancreatic adenocarcinoma

    In development [GID-IPG10067] Expected publication date: TBC

    Interventional procedures guidance
    In development